Live

biotech-tech hybrid

1 articles

Lilly Bets $10B on AI and Neuroscience to Diversify Beyond GLP-1 Boom

Investing.com

Investing.com·3d ago·Jeffrey Neal Johnson

Lilly Bets $10B on AI and Neuroscience to Diversify Beyond GLP-1 Boom

Eli Lilly commits $10B to AI drug discovery partnership and sleep disorders acquisition, diversifying beyond its GLP-1 franchise.

LLYCNTArevenue diversificationartificial intelligence